Suchergebnisse - "Goadsby, Peter"

PubPharm (49)

1

Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed : LIBERTY 3-Year Study

enthalten in: Neurology | 2024

von Reuter, U. | Goadsby, P. | Ferrari, M. | +9

2

Ubrogepant for the treatment of migraine attacks during the prodrome : a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA

enthalten in: Lancet (London, England) | 2023

von Dodick, D. | Goadsby, P. | Schwedt, T. | +7

3

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA : a phase 3, double-blind, randomised, placebo-controlled multicentre trial

enthalten in: The Lancet. Neurology | 2023

von Lipton, R. | Croop, R. | Stock, D. | +6

CommentIn: Lancet Neurol. 2023 Mar;22(3):190-191. - PMID 36804077

4

Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study

enthalten in: The journal of headache and pain | 2022

von Barbanti, P. | Goadsby, P. | Lambru, G. | +5

5

Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures : results from the LIBERTY study

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2022

von Ferrari, M. | Reuter, U. | Goadsby, P. | +7

6

Atogepant for the Preventive Treatment of Migraine

enthalten in: The New England journal of medicine | 2021

von Ailani, J. | Lipton, R. | Goadsby, P. | +106

7

Chronic versus episodic migraine : The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency

enthalten in: Headache | 2021

von Ishii, R. | Schwedt, T. | Dumkrieger, G. | +8

CommentIn: Headache. 2021 Oct;61(9):1460-1461. - PMID 34601727

8

Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful : results from the LIBERTY study

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2021

von Lanteri-Minet, M. | Goadsby, P. | Reuter, U. | +4

9

Efficacy of ubrogepant based on prior exposure and response to triptans : A post hoc analysis

enthalten in: Headache | 2021

von Blumenfeld, A. | Goadsby, P. | Dodick, D. | +5

CommentIn: Headache. 2021 Mar;61(3):407-408. - PMID 33755995

10

Oral rimegepant for preventive treatment of migraine : a phase 2/3, randomised, double-blind, placebo-controlled trial

enthalten in: Lancet (London, England) | 2021

von Croop, R. | Lipton, R. | Kudrow, D. | +6

CommentIn: Lancet. 2021 Jan 2;397(10268):4-5. - PMID 33338436

1
2
3
4
5
Nächster »
[5]